However, it is unknown whether and how interfering with E2F function influences tumor progression of human breast cancer cells, particularly of Her2+ (Her2+ER−PR−) tumors, which is one of the two most aggressive and poorly prognostic breast cancer subtypes [22]. The gene discussed is ERBB2; the disease is neoplasm.